TLC, HPTLC FINGERPRINTING AND ACUTE ORAL TOXICITY EVALUATION OF HABB-E-AZARAQI: A NUX-VOMICA-BASED TRADITIONAL UNANI FORMULATION |
Ara, Shabnam Anjum
(Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital)
Viquar, Uzma (Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital) Zakir, Mohammed (Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital) Husain, Gulam Mohammed (Pharmacology and Toxicology Laboratory, National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital) Naikodi, Mohammed Abdul Rasheed (Drug Standardization Research Unit, National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital) Urooj, Mohd (Pharmacology and Toxicology Laboratory, National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital) Kazmi, Munawwar Husain (Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital) |
1 | Folashade KO, Omoregie HE, Ochogu AP. Standardization of herbal medicines-A review. Int J Biodiverse Conserv.2012; 4:101-12. |
2 | Latif HA. Qarabadeen-e- Majeedi. All India Unani Tibbi Conference, Delhi, p.69,1986. |
3 | OECD test guideline no. 425. Acute Oral Toxicity: Up-and Down-Procedure (UDP), 2008. Available at:https://www.oecd.org/env/test-no425-acute-oral-toxicityup-and-down-procedure9789264071049-en.htm. (accessed on 28th Apr 2020). |
4 | OECD. Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents. edn. OECD Publishing,1998. |
5 | Purohit MG, Vyas SP. Medicinal Plant Cultivation, A Scientific Approach including Processing and Financial Guidelines, Agrobios, Jodhpur, India, pp.198-99,206-210,2004. |
6 | Tariq NA. Taj-ul-Mufradat. Idara Kitab-ul-Shifa, New Delhi, p. 545, 2004. |
7 | World Health Organization. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine; 1-2,2000.Available at: https://apps.who.int/iris/handle/10665/66783.(accessed on 28th Apr 2020). |
8 | Anonymous. National Formulary of Unani Medicine, Government of India, First Edition, I (I), (New Delhi, India: CCRUM, Department of AYUSH, Ministry of Health and Family Welfare), p.47, 1981. |
9 | Anonymous. National Formulary of Unani Medicine, Government of India, First Edition, I (I), (New Delhi, India: CCRUM, Department of AYUSH, Ministry of Health and Family Welfare), pp. 185-186, 2007. |
10 | Anonymous. Unani Pharmacopoeia of India. Government of India, First Edition, I (II), (New Delhi, India: CCRUM, Department of AYUSH, Ministry of Health and Family Welfare), pp. 15-16,38- 40,110, 2006. |
11 | ICH ICoH. Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals M3(R2), pp.8-9,2009. |
12 | Anwar N, Khan MS, Kabir H, Ahmad S. Effect of detoxification (tad beer) in content of toxic metabolites of Strychnos nux-vomica: A Unani approach for its use in human. J Pharm Bio Allied Sci. 2015; 7(4): 314-6. DOI |
13 | CPCSEA. CPCSEA Standard Operating Procedures (SOP) for IAEC, New Delhi: Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), pp. 41-42, 2010. |
14 | Ghani N. Khazainul Advia. Idara Kitab-ul-Shifa, New Delhi, pp. 203-205, 495-496,1027-1028, 1231-1233, 2011. |
15 | Kabeeruddin HK. Bayaz-e-Kabeer. Central Council for Research in Unani Medicine, New Delhi;1(2), p.38,2008. |
16 | Khan HK. Qarabadeen-e-Azam. Ajaz Publishing House, Delhi, pp. 36, 44,402-404,406,494,492,1996. |